InvestorsHub Logo
Followers 0
Posts 464
Boards Moderated 0
Alias Born 09/23/2014

Re: None

Wednesday, 07/29/2015 5:10:04 AM

Wednesday, July 29, 2015 5:10:04 AM

Post# of 423548
Watch out for the results of this PCSK9 outcomes trial down the line:
https://clinicaltrials.gov/ct2/show/NCT01663402

The Estimated Primary Completion Date is December 2017, coincidently, the exact same Estimated Primary Completion date as R-IT's:
https://clinicaltrials.gov/ct2/show/NCT01492361

PCSK9's are complete and utter garbage despite what that scientific genius Ajax113 and other shills would have you believe. They may significantly lower LDL-C, but there will be a slew of side-effects for patients to contend with, none of which will be associated with Vascepa. Anyone who truly understands what LDL-C is and what its functions are, and who understands Vascepa's precise mechanisms of action, will have no problem understanding why this will be the case.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News